Biologic ‘comes up trumps’ for teen eczema

The monoclonal antibody has 'excellent efficacy' and this real-world study demonstrates its safety, researchers say

Dupilumab is a highly effective and safe treatment option for moderate to severe atopic dermatitis in teenagers, a multicentre study shows.

In fact, Italian dermatologists say improvements in clinical symptom scores documented in their cohort were greater than or comparable to those observed in recent clinical trials.